246 related articles for article (PubMed ID: 12526561)
21. Mechanistic flexibility in the reduction of copper(II) complexes of aliphatic polyamines by mercapto amino acids.
Anderson CH; Holwerda RA
J Inorg Biochem; 1985 Jan; 23(1):29-41. PubMed ID: 3981165
[TBL] [Abstract][Full Text] [Related]
22. Novel approaches to polynuclear platinum pro-drugs. Selective release of cytotoxic platinum-spermidine species through hydrolytic cleavage of carbamates.
Hegmans A; Qu Y; Kelland LR; Roberts JD; Farrell N
Inorg Chem; 2001 Nov; 40(24):6108-14. PubMed ID: 11703107
[TBL] [Abstract][Full Text] [Related]
23. Platinum(II) catalysis and radical intervention in reductions of platinum(IV) antitumor drugs by ascorbic acid.
Weaver EL; Bose RN
J Inorg Biochem; 2003 Jul; 95(4):231-9. PubMed ID: 12818793
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and X-ray crystal structure of trans,cis-[Pt(OAc)2I2(en)]: a novel type of cisplatin analog that can be photolyzed by visible light to DNA-binding and cytotoxic species in vitro.
Kratochwil NA; Zabel M; Range KJ; Bednarski PJ
J Med Chem; 1996 Jun; 39(13):2499-507. PubMed ID: 8691447
[TBL] [Abstract][Full Text] [Related]
25. Platinum(IV) analogues of AMD473 (cis-[PtCl2(NH3)(2-picoline)]): preparative, structural, and electrochemical studies.
Battle AR; Choi R; Hibbs DE; Hambley TW
Inorg Chem; 2006 Aug; 45(16):6317-22. PubMed ID: 16878941
[TBL] [Abstract][Full Text] [Related]
26. trans-Platinum(iv) pro-drugs that exhibit unusual resistance to reduction by endogenous reductants and blood serum but are rapidly activated inside cells:
Chen CKJ; Kappen P; Gibson D; Hambley TW
Dalton Trans; 2020 Jun; 49(23):7722-7736. PubMed ID: 32469362
[TBL] [Abstract][Full Text] [Related]
27. Photoactivatable platinum complexes.
Bednarski PJ; Mackay FS; Sadler PJ
Anticancer Agents Med Chem; 2007 Jan; 7(1):75-93. PubMed ID: 17266506
[TBL] [Abstract][Full Text] [Related]
28. Insight into the Electrochemical Reduction Mechanism of Pt(IV) Anticancer Complexes.
Tolbatov I; Coletti C; Marrone A; Re N
Inorg Chem; 2018 Mar; 57(6):3411-3419. PubMed ID: 29509010
[TBL] [Abstract][Full Text] [Related]
29. Polycyclic aromatic hydrocarbon (PAH) ortho-quinone conjugate chemistry: kinetics of thiol addition to PAH ortho-quinones and structures of thioether adducts of naphthalene-1,2-dione.
Murty VS; Penning TM
Chem Biol Interact; 1992 Sep; 84(2):169-88. PubMed ID: 1394622
[TBL] [Abstract][Full Text] [Related]
30. Reactions of a photoactivatable diazido Pt(iv) anticancer complex with a single-stranded oligodeoxynucleotide.
Liang Z; Lin J; Gong X; Cheng Y; Huang C; Zhang J; Wu X; Wang F; Zhao Y; Wu K
Dalton Trans; 2020 Aug; 49(32):11249-11259. PubMed ID: 32756682
[TBL] [Abstract][Full Text] [Related]
31. Kinetics and mechanism of oxidation of the anti-tubercular prodrug isoniazid and its analog by iridium(iv) as models for biological redox systems.
Dong J; Ren Y; Sun S; Yang J; Nan C; Shi H; Xu J; Duan J; Shi T; Elding LI
Dalton Trans; 2017 Jul; 46(26):8377-8386. PubMed ID: 28621793
[TBL] [Abstract][Full Text] [Related]
32. Direct oxidation of L-cysteine by [FeIII(bpy)2(CN)2]+ and [FeIII(bpy)(CN)4]-.
Wang X; Stanbury DM
Inorg Chem; 2008 Feb; 47(3):1224-36. PubMed ID: 18177037
[TBL] [Abstract][Full Text] [Related]
33. Effects of redox buffer properties on the folding of a disulfide-containing protein: dependence upon pH, thiol pKa, and thiol concentration.
Gough JD; Lees WJ
J Biotechnol; 2005 Feb; 115(3):279-90. PubMed ID: 15639090
[TBL] [Abstract][Full Text] [Related]
34. DNA-binding properties of novel cis- and trans platinum-based anticancer agents in 2 human ovarian carcinoma cell lines.
Mellish KJ; Barnard CF; Murrer BA; Kelland LR
Int J Cancer; 1995 Sep; 62(6):717-23. PubMed ID: 7558420
[TBL] [Abstract][Full Text] [Related]
35. Oxidation of anticancer Pt(II) complexes with monodentate phosphane ligands: towards stable but active Pt(IV) prodrugs.
Medrano MÁ; Álvarez-Valdés A; Perles J; Lloret-Fillol J; Muñoz-Galván S; Carnero A; Navarro-Ranninger C; Quiroga AG
Chem Commun (Camb); 2013 May; 49(42):4806-8. PubMed ID: 23591566
[TBL] [Abstract][Full Text] [Related]
36. Antitumor Platinium(IV) Prodrugs: A Systematic Computational Exploration of Their Reduction Mechanism by l-Ascorbic Acid.
Dabbish E; Ponte F; Russo N; Sicilia E
Inorg Chem; 2019 Mar; 58(6):3851-3860. PubMed ID: 30843385
[TBL] [Abstract][Full Text] [Related]
37. Kinetics of the reaction between nitroxide and thiyl radicals: nitroxides as antioxidants in the presence of thiols.
Goldstein S; Samuni A; Merenyi G
J Phys Chem A; 2008 Sep; 112(37):8600-5. PubMed ID: 18729428
[TBL] [Abstract][Full Text] [Related]
38. Reduction of [VO2(ma)2]- and [VO2(ema)2]- by ascorbic acid and glutathione: kinetic studies of pro-drugs for the enhancement of insulin action.
Song B; Aebischer N; Orvig C
Inorg Chem; 2002 Mar; 41(6):1357-64. PubMed ID: 11896702
[TBL] [Abstract][Full Text] [Related]
39. Insights into the acid-base properties of Pt(IV)-diazidodiam(m)inedihyroxido complexes from multinuclear NMR spectroscopy.
Ronconi L; Pizarro AM; McQuitty RJ; Sadler PJ
Chemistry; 2011 Oct; 17(43):12051-8. PubMed ID: 21922567
[TBL] [Abstract][Full Text] [Related]
40. Studies on the photoactivation of two cytotoxic trans,trans,trans-diazidodiaminodihydroxo-Pt(IV) complexes.
Westendorf AF; Bodtke A; Bednarski PJ
Dalton Trans; 2011 May; 40(19):5342-51. PubMed ID: 21461431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
